| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology (M.O.v.A., A.M.P., N.R.B., S.W.v.T., H.C.H., J.W.A.S., F.R., J.A.R.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands; and Erasmus Medical Center (S.W.J.L.), 3000 DR Rotterdam, The Netherlands
Address all correspondence and requests for reprints to: J. A. Romijn, M.D., Department of Endocrinology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: j.a.romijn{at}lumc.nl.
To evaluate the long-term impact of cured Cushings disease on subjective well-being, we assessed quality of life by validated health-related questionnaires in 58 patients cured from Cushings disease by transsphenoidal surgery (n = 58), some of whom received additional radiotherapy (n = 11) and/or bilateral adrenalectomy (n = 3). The mean duration of remission was 13.4 ± 6.7 yr (range of 225 yr). Patient data were compared with a control group of 98 healthy subjects with the same age and sex distribution and with age-adjusted reference values available from the literature.
General perceived well-being, measured by the Nottingham Health Profile and the Short Form, was reduced compared with controls for all subscales (P < 0.001). Patients with Cushings disease had worse scores on subscales of fatigue Multidimensional Fatigue Index and anxiety and depression (Hospital Anxiety and Depression Scale). Compared with reference values from the literature, quality of life was also reduced in the patients according to all questionnaires and all items, except pain (Short Form), sleep (Nottingham Health Profile), and reduced activity (Multidimensional Fatigue Index). Despite conventional hormone replacement therapy, hypopituitarism was an important independent predictor of reduced quality of life. Patients without hypopituitarism (n = 28) showed reduced scores on physical items but normal scores on mental items compared with controls.
In conclusion, despite long-term cure of Cushings disease, patients experience a considerable decrease in quality of life, with physical and psychosocial impairments, especially in the presence of hypopituitarism.
This article has been cited by other articles:
![]() |
S M Webb, X Badia, M J Barahona, A Colao, C J Strasburger, A Tabarin, M O van Aken, R Pivonello, G Stalla, S W J Lamberts, et al. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire Eur. J. Endocrinol., May 1, 2008; 158(5): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Havekes, A A van der Klaauw, H C Hoftijzer, J C Jansen, A G L van der Mey, A H J T Vriends, J W A Smit, J A Romijn, and E P M Corssmit Reduced quality of life in patients with head-and-neck paragangliomas Eur. J. Endocrinol., February 1, 2008; 158(2): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hoftijzer, K. A. Heemstra, E. P. M. Corssmit, A. A. van der Klaauw, J. A. Romijn, and J. W. A. Smit Quality of Life in Cured Patients with Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 200 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.-C. Koschker, M. Quinkler, O. Decker, W. Arlt, and B. Allolio Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3912 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kars, A A van der Klaauw, C S Onstein, A M Pereira, and J A Romijn Quality of life is decreased in female patients treated for microprolactinoma Eur. J. Endocrinol., August 1, 2007; 157(2): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pecori Giraldi, M. Andrioli, L. De Marinis, A. Bianchi, A. Giampietro, M. De Martin, E. Sacco, M. Scacchi, A. Pontecorvi, and F. Cavagnini Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease Eur. J. Endocrinol., February 1, 2007; 156(2): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Dekkers, A. A. van der Klaauw, A. M. Pereira, N. R. Biermasz, P. J. Honkoop, F. Roelfsema, J. W. A. Smit, and J. A. Romijn Quality of Life Is Decreased after Treatment for Nonfunctioning Pituitary Macroadenoma J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3364 - 3369. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Dekkers, A. M. Pereira, F. Roelfsema, J. H. C. Voormolen, K. J. Neelis, M. A. Schroijen, J. W. A. Smit, and J. A. Romijn Observation Alone after Transsphenoidal Surgery for Nonfunctioning Pituitary Macroadenoma J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1796 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
O M Dekkers, N R Biermasz, J W A Smit, L E Groot, F Roelfsema, J A Romijn, and A M Pereira Quality of life in treated adult craniopharyngioma patients. Eur. J. Endocrinol., March 1, 2006; 154(3): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lindsay, T. Nansel, S. Baid, J. Gumowski, and L. K. Nieman Long-Term Impaired Quality of Life in Cushing's Syndrome despite Initial Improvement after Surgical Remission J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |